Evidence map›Paper›PMID 26206403›Full record

ArticleAAPS PharmSciTech2016

Development of an Abuse- and Alcohol-Resistant Formulation Based on Hot-Melt Extrusion and Film Coating.

Nicole Jedinger, Simone Schrank, Johannes M Fischer, Karlheinz Breinhälter, Johannes Khinast, Eva Roblegg

Abstract read
In one paragraph

Article in AAPS PharmSciTech, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Pharmaceutical Thermal Processing.AAPS PharmSciTech · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nicole JedingerResearch Center Pharmaceutical Engineering, Graz, Austria.
Simone SchrankDepartment of Pharmaceutical Technology, Institute of Pharmaceutical Sciences, University of Graz, Universitätsplatz 1, A- 8010, Graz, Austria.
Johannes M FischerResearch Center Pharmaceutical Engineering, Graz, Austria.
Karlheinz BreinhälterResearch Center Pharmaceutical Engineering, Graz, Austria.
Johannes KhinastResearch Center Pharmaceutical Engineering, Graz, Austria.
Eva RobleggResearch Center Pharmaceutical Engineering, Graz, Austria. eva.roblegg@uni-graz.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study focused on the development of flexible (i.e., deformable) multiple-unit pellets that feature (i) a prolonged drug release, (ii) drug abuse deterrence, and (iii) a minimal risk of alcohol-induced dose dumping (ADD). Deformable pellets were prepared via an advanced continuous one-step hot-melt extrusion (HME) technique, with the drug (i.e., antipyrine and codeine phosphate) fed as an aqueous solution into the molten matrix material (i.e., cornstarch, gum arabic, and xanthan). Formulations that had suitable mechanical characteristics (i.e., high compression strength) were coated with a flexible Aquacoat(®) ARC film to ensure prolonged release and to avoid ADD. The pellets were characterized in terms of their mechanical properties and in vitro drug release behavior in alcoholic media. All formulations were abuse deterrent: they had a high compression strength and grinding the pellets into powder was impossible. Since the pellets comprising gum arabic and xanthan as a matrix did not remain intact during dissolution testing, they had a very fast drug release rate. Cornstarch-based pellets that swelled but remained intact in the dissolution media had a slower drug release. Coated cornstarch-based pellets had a prolonged release over 8 h and resistance to dose dumping in 20 and 40% ethanol. Our results indicate that cornstarch-based pellets manufactured via the advanced HME process followed by coating are a promising formulation that makes tampering difficult due to a high compression strength combined with robustness in alcoholic media.

Indexed as

CelluloseChemistry, PharmaceuticalDelayed-Action PreparationsDrug CompoundingDrug LiberationDrug StabilityEthanolExcipientsGum ArabicHot TemperaturePharmaceutical PreparationsPolysaccharides, BacterialPowdersSolubilityStarchCelluloseDelayed-Action PreparationsEthanolethyl celluloseExcipientsGum ArabicPharmaceutical PreparationsPolysaccharides, BacterialPowdersStarchxanthan gumdose dumpingdrug tamperingmelt extrusionstarch

Identifiers

PMID26206403
PMCPMC4766125

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.